1. Home
  2. CMPS vs PKST Comparison

CMPS vs PKST Comparison

Compare CMPS & PKST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CMPS
  • PKST
  • Stock Information
  • Founded
  • CMPS 2020
  • PKST 2008
  • Country
  • CMPS United Kingdom
  • PKST United States
  • Employees
  • CMPS N/A
  • PKST N/A
  • Industry
  • CMPS Biotechnology: Pharmaceutical Preparations
  • PKST Real Estate Investment Trusts
  • Sector
  • CMPS Health Care
  • PKST Real Estate
  • Exchange
  • CMPS Nasdaq
  • PKST Nasdaq
  • Market Cap
  • CMPS 364.9M
  • PKST 419.1M
  • IPO Year
  • CMPS 2020
  • PKST N/A
  • Fundamental
  • Price
  • CMPS $4.59
  • PKST $12.80
  • Analyst Decision
  • CMPS Strong Buy
  • PKST Buy
  • Analyst Count
  • CMPS 7
  • PKST 2
  • Target Price
  • CMPS $18.83
  • PKST $15.50
  • AVG Volume (30 Days)
  • CMPS 1.1M
  • PKST 127.9K
  • Earning Date
  • CMPS 07-31-2025
  • PKST 05-08-2025
  • Dividend Yield
  • CMPS N/A
  • PKST 7.08%
  • EPS Growth
  • CMPS N/A
  • PKST N/A
  • EPS
  • CMPS N/A
  • PKST N/A
  • Revenue
  • CMPS N/A
  • PKST $225,817,000.00
  • Revenue This Year
  • CMPS N/A
  • PKST N/A
  • Revenue Next Year
  • CMPS N/A
  • PKST N/A
  • P/E Ratio
  • CMPS N/A
  • PKST N/A
  • Revenue Growth
  • CMPS N/A
  • PKST 5.64
  • 52 Week Low
  • CMPS $2.49
  • PKST $9.89
  • 52 Week High
  • CMPS $8.54
  • PKST $16.26
  • Technical
  • Relative Strength Index (RSI)
  • CMPS 64.81
  • PKST 65.48
  • Support Level
  • CMPS $3.86
  • PKST $12.07
  • Resistance Level
  • CMPS $4.52
  • PKST $12.75
  • Average True Range (ATR)
  • CMPS 0.36
  • PKST 0.42
  • MACD
  • CMPS 0.00
  • PKST 0.07
  • Stochastic Oscillator
  • CMPS 65.63
  • PKST 96.49

About CMPS COMPASS Pathways Plc American Depository Shares

Compass Pathways PLC is a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health. The company is motivated by the need to find ways to help and empower people suffering with mental health challenges who are not helped by existing therapies and are pioneering the development of a new model of psilocybin therapy, in which psilocybin is administered in conjunction with psychological support. Its focus is on treatment-resistant depression, or TRD, a subset of major depressive disorder, or MDD, comprising patients who are inadequately served by the treatment paradigm. It has developed a proprietary, high-purity polymorphic crystalline formulation of psilocybin, COMP360.

About PKST Peakstone Realty Trust

Peakstone Realty Trust is an internally managed, publicly registered real estate investment trust (REIT) that owns and operates predominately single-tenant industrial and office properties with creditworthy tenants and long-term leases. Peakstone's portfolio consists of newer vintage, and well-located real estate assets in majorly high-growth coastal and sunbelt markets. The company has two reportable segments: Industrial and Office. The Industrial segment consists of industrial outdoor storage properties which have a low building-to-land ratio, or low coverage, maximizing yard space for the display, movement, and storage of materials and equipment. The Office segment includes office, R&D and data center properties.

Share on Social Networks: